Financhill
Back

Roivant Sciences Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
44

ROIV
Roivant Sciences

Last Price:
$11.58
Seasonality Move:
-15.05%
Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
$0.60
Seasonality Move:
36.97%
Sell
44
Roivant Sciences (ROIV) is a Sell

Is Roivant Sciences a Buy, Sell or Hold?

  • The current Roivant Sciences [ROIV] share price is $11.57. The Score for ROIV is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ROIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.60. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ROIV Stock Price Chart

What is Roivant Sciences's stock price today?

  • The Roivant Sciences share price today is $11.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROIV is experiencing slight buying pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

ROIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 41.56 Sell
Chaikin Money Flow: 3262439 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.57 - 12.47) Sell
Bollinger Bands (100): (11.23 - 12.21) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.3 Sell
Chaikin Money Flow: 3030174 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.7) Sell
Bollinger Bands (100): (0.69 - 1.09) Sell

ROIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.86 Sell
20-day SMA: 12.17 Sell
50-day SMA: 11.89 Sell
200-day SMA: 11.29 Buy
8-day EMA: 11.82 Sell
20-day EMA: 11.95 Sell
50-day EMA: 11.89 Sell
200-day EMA: 11.35 Buy

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.65 Sell
50-day SMA: 0.72 Sell
200-day SMA: 1.04 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.64 Sell
50-day EMA: 0.73 Sell
200-day EMA: 0.93 Sell

Roivant Sciences Earnings Growth & ROIV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.21 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.

Roivant Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):